Keith S. Wong

1.3k total citations
17 papers, 528 citations indexed

About

Keith S. Wong is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Keith S. Wong has authored 17 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Oncology. Recurrent topics in Keith S. Wong's work include Biochemical and Structural Characterization (4 papers), Mitochondrial Function and Pathology (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Keith S. Wong is often cited by papers focused on Biochemical and Structural Characterization (4 papers), Mitochondrial Function and Pathology (4 papers) and Bacterial Genetics and Biotechnology (4 papers). Keith S. Wong collaborates with scholars based in Canada, United States and France. Keith S. Wong's co-authors include Walid A. Houry, Robert A. Batey, Mark Mabanglo, Vaibhav Bhandari, Jin Zhou, David M. Irwin, Elisa Leung, Jordan D. Goodreid, Scott D. Gray‐Owen and Mohan Babu and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Scientific Reports.

In The Last Decade

Keith S. Wong

17 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith S. Wong Canada 13 388 85 80 62 57 17 528
Jan Félix France 13 323 0.8× 100 1.2× 66 0.8× 67 1.1× 31 0.5× 22 611
Karl Brillet France 15 416 1.1× 203 2.4× 33 0.4× 46 0.7× 27 0.5× 31 648
Ariane Proteau Canada 13 452 1.2× 103 1.2× 36 0.5× 123 2.0× 35 0.6× 13 707
Dev Mangroo Canada 20 751 1.9× 104 1.2× 92 1.1× 31 0.5× 24 0.4× 46 905
Jacob Lesniak United States 7 353 0.9× 48 0.6× 37 0.5× 60 1.0× 26 0.5× 8 555
John A. Buglino United States 14 762 2.0× 196 2.3× 65 0.8× 148 2.4× 111 1.9× 18 986
Linda A. Egger United States 14 470 1.2× 195 2.3× 60 0.8× 27 0.4× 33 0.6× 17 750
Patrick Hauske Germany 11 302 0.8× 80 0.9× 33 0.4× 90 1.5× 24 0.4× 13 457
Miao‐Hsia Lin Taiwan 13 386 1.0× 48 0.6× 49 0.6× 36 0.6× 20 0.4× 26 539
Yongbin Xu China 12 299 0.8× 150 1.8× 60 0.8× 25 0.4× 31 0.5× 22 546

Countries citing papers authored by Keith S. Wong

Since Specialization
Citations

This map shows the geographic impact of Keith S. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith S. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith S. Wong more than expected).

Fields of papers citing papers by Keith S. Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith S. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith S. Wong. The network helps show where Keith S. Wong may publish in the future.

Co-authorship network of co-authors of Keith S. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Keith S. Wong. A scholar is included among the top collaborators of Keith S. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith S. Wong. Keith S. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mabanglo, Mark, Keith S. Wong, Jingping Shen, et al.. (2025). Small molecule dysregulation of ClpP activity via bidirectional allosteric pathways. Structure. 33(10). 1700–1716.e6. 1 indexed citations
2.
Park, Ji Eun, Aaron Wilson, Kristy Berry, et al.. (2025). Highly specific Immunoproteasome inhibitor M3258 induces proteotoxic stress and apoptosis in KMT2A::AFF1 driven acute lymphoblastic leukemia. Scientific Reports. 15(1). 17284–17284. 3 indexed citations
3.
Mabanglo, Mark, Jin Zhou, Keith S. Wong, et al.. (2024). Structure-Based Design and Development of Phosphine Oxides as a Novel Chemotype for Antibiotics that Dysregulate Bacterial ClpP Proteases. Journal of Medicinal Chemistry. 67(17). 15131–15147. 8 indexed citations
4.
Mabanglo, Mark, Keith S. Wong, Elisa Leung, et al.. (2022). Potent ClpP agonists with anticancer properties bind with improved structural complementarity and alter the mitochondrial N-terminome. Structure. 31(2). 185–200.e10. 31 indexed citations
5.
Bhandari, Vaibhav, et al.. (2022). Analysis of the Evolution of the MoxR ATPases. The Journal of Physical Chemistry A. 126(29). 4734–4746. 4 indexed citations
6.
Mabanglo, Mark, Jordan D. Goodreid, Elisa Leung, et al.. (2020). Development of Antibiotics That Dysregulate the Neisserial ClpP Protease. ACS Infectious Diseases. 6(12). 3224–3236. 23 indexed citations
7.
Wong, Keith S. & Walid A. Houry. (2019). Recent Advances in Targeting Human Mitochondrial AAA+ Proteases to Develop Novel Cancer Therapeutics. Advances in experimental medicine and biology. 119–142. 13 indexed citations
8.
Wong, Keith S. & Walid A. Houry. (2019). Chemical Modulation of Human Mitochondrial ClpP: Potential Application in Cancer Therapeutics. ACS Chemical Biology. 14(11). 2349–2360. 40 indexed citations
9.
Wong, Keith S., Mark Mabanglo, Thiago Vargas Seraphim, et al.. (2018). Acyldepsipeptide Analogs Dysregulate Human Mitochondrial ClpP Protease Activity and Cause Apoptotic Cell Death. Cell chemical biology. 25(8). 1017–1030.e9. 77 indexed citations
10.
Bhandari, Vaibhav, Keith S. Wong, Jin Zhou, et al.. (2018). The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases. ACS Chemical Biology. 13(6). 1413–1425. 114 indexed citations
11.
Goodreid, Jordan D., John Janetzko, John P. Santa Maria, et al.. (2016). Development and Characterization of Potent Cyclic Acyldepsipeptide Analogues with Increased Antimicrobial Activity. Journal of Medicinal Chemistry. 59(2). 624–646. 46 indexed citations
12.
Wong, Keith S., Vaibhav Bhandari, Sarath Chandra Janga, & Walid A. Houry. (2016). The RavA-ViaA Chaperone-Like System Interacts with and Modulates the Activity of the Fumarate Reductase Respiratory Complex. Journal of Molecular Biology. 429(2). 324–344. 25 indexed citations
13.
Wong, Keith S., Jamie Snider, Chris Graham, et al.. (2014). The MoxR ATPase RavA and Its Cofactor ViaA Interact with the NADH:Ubiquinone Oxidoreductase I in Escherichia coli. PLoS ONE. 9(1). e85529–e85529. 34 indexed citations
14.
Goodreid, Jordan D., Keith S. Wong, Elisa Leung, et al.. (2014). Total Synthesis and Antibacterial Testing of the A54556 Cyclic Acyldepsipeptides Isolated from Streptomyces hawaiiensis. Journal of Natural Products. 77(10). 2170–2181. 26 indexed citations
15.
Wong, Keith S. & Walid A. Houry. (2012). Novel structural and functional insights into the MoxR family of AAA+ ATPases. Journal of Structural Biology. 179(2). 211–221. 33 indexed citations
16.
Wong, Keith S. & Walid A. Houry. (2006). Hsp90 at the crossroads of genetics and epigenetics. Cell Research. 16(9). 742–749. 19 indexed citations
17.
Irwin, David M. & Keith S. Wong. (2005). Evolution of New Hormone Function: Loss and Gain of a Receptor. Journal of Heredity. 96(3). 205–211. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026